Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
226330
vs
K
KOSPI 200
Over the past 12 months, SyntekaBio Inc has underperformed KOSPI 200, delivering a return of -63% compared to KOSPI 200's +119% growth.
Stocks Performance
226330 vs KOSPI 200
Performance Gap
226330 vs KOSPI 200
Performance By Year
226330 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SyntekaBio Inc
Glance View
SyntekaBio Inc is a South Korean biotech company that uses artificial intelligence and bioinformatics to help find new drug candidates and analyze biological data. It builds software tools and research services that can screen molecules, study gene and protein patterns, and support drug development work for pharmaceutical and biotech customers. The company makes money mainly by selling research and development services, software tools, and project work to drugmakers, hospitals, and research groups. Its customers use these tools to shorten early-stage discovery, understand disease biology, and design better experiments before committing to expensive lab and clinical work. What makes SyntekaBio different is that it sits at the data and discovery layer of drug development rather than making finished medicines itself. It is part technology vendor, part research partner, which means its business depends on turning complex biological data into useful predictions and work products that drug developers are willing to pay for.